These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22348353)

  • 1. Dried blood spots in toxicology: from the cradle to the grave?
    Stove CP; Ingels AS; De Kesel PM; Lambert WE
    Crit Rev Toxicol; 2012 Mar; 42(3):230-43. PubMed ID: 22348353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spot them in the spot: analysis of abused substances using dried blood spots.
    Sadones N; Capiau S; De Kesel PM; Lambert WE; Stove CP
    Bioanalysis; 2014 Aug; 6(17):2211-27. PubMed ID: 25383733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice.
    Wong P; Pham R; Whitely C; Soto M; Salyers K; James C; Bruenner BA
    J Pharm Biomed Anal; 2011 Nov; 56(3):604-8. PubMed ID: 21784595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of mass spectrometry to analyze dried blood spots.
    Wagner M; Tonoli D; Varesio E; Hopfgartner G
    Mass Spectrom Rev; 2016; 35(3):361-438. PubMed ID: 25252132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery.
    Sleczka BG; D'Arienzo CJ; Tymiak AA; Olah TV
    Bioanalysis; 2012 Jan; 4(1):29-40. PubMed ID: 22191592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is next for dried blood spots?
    Ji QC; Liu G; D'Arienzo CJ; Olah TV; Arnold ME
    Bioanalysis; 2012 Aug; 4(16):2059-65. PubMed ID: 22946921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assay.
    Xiang Y; Welch M; Amaravadi L; Stebbins C
    J Immunol Methods; 2013 Jul; 393(1-2):53-60. PubMed ID: 23603618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dried blood spots in therapeutic drug monitoring and toxicology.
    Velghe S; De Troyer R; Stove C
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):1-3. PubMed ID: 29205069
    [No Abstract]   [Full Text] [Related]  

  • 9. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.
    Li F; Ploch S; Fast D; Michael S
    J Mass Spectrom; 2012 May; 47(5):655-67. PubMed ID: 22576879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
    Edelbroek PM; van der Heijden J; Stolk LM
    Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring.
    Antunes MV; Charão MF; Linden R
    Clin Biochem; 2016 Sep; 49(13-14):1035-46. PubMed ID: 27179588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.
    Mercolini L; Mandrioli R; Protti M; Conca A; Albers LJ; Raggi MA
    Bioanalysis; 2014 Jun; 6(11):1487-95. PubMed ID: 25046049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
    Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
    Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
    Capiau S; Veenhof H; Koster RA; Bergqvist Y; Boettcher M; Halmingh O; Keevil BG; Koch BCP; Linden R; Pistos C; Stolk LM; Touw DJ; Stove CP; Alffenaar JC
    Ther Drug Monit; 2019 Aug; 41(4):409-430. PubMed ID: 31268966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical feasibility of dried blood spots: Analytics, validation, and applications.
    Enderle Y; Foerster K; Burhenne J
    J Pharm Biomed Anal; 2016 Oct; 130():231-243. PubMed ID: 27390013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dried blood spots in bioanalysis of antimalarials: relevance and challenges in quantitative assessment of antimalarial drugs.
    Taneja I; Erukala M; Raju KS; Singh SP; Wahajuddin
    Bioanalysis; 2013 Sep; 5(17):2171-86. PubMed ID: 23962252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dried blood spots: concepts, present status, and future perspectives in bioanalysis.
    Sharma A; Jaiswal S; Shukla M; Lal J
    Drug Test Anal; 2014 May; 6(5):399-414. PubMed ID: 24692095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer.
    Capiau S; Stove VV; Lambert WE; Stove CP
    Anal Chem; 2013 Jan; 85(1):404-10. PubMed ID: 23190205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spots: a new tool for tuberculosis treatment optimization.
    Vu DH; Alffenaar JW; Edelbroek PM; Brouwers JR; Uges DR
    Curr Pharm Des; 2011; 17(27):2931-9. PubMed ID: 21834763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities.
    Müller IR; Linden G; Charão MF; Antunes MV; Linden R
    Expert Rev Clin Pharmacol; 2023; 16(8):691-701. PubMed ID: 37300458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.